Octreotide in a Critically Ill Extremely Preterm Infant With Perforated Necrotizing Enterocolitis

Area of Science:

• Neonatalogy
• Pediatric Surgery
• Gastroenterology

Background:

• Necrotizing enterocolitis (NEC) is a critical gastrointestinal complication in premature infants.
• Surgical intervention is the standard treatment for perforated NEC, but is not always feasible.
• Limited evidence exists for medical treatments as alternatives or adjuncts to surgery in complex NEC cases.

Observation:

• A case study of an extremely low birth weight infant with perforated NEC is presented.
• The infant had undergone initial surgical interventions (peritoneal drainage and laparotomy) without success.
• The infant's critical condition precluded further surgical options.

Findings:

• Off-label octreotide treatment was administered due to contraindications for further surgery.
• The infant showed gradual clinical improvement, with reduced peritoneal output and resolution of pneumoperitoneum.
• No adverse events were reported during octreotide administration, and no relapse occurred after discontinuation.

Implications:

• Octreotide may represent a viable off-label medical treatment option for perforated NEC in critically ill neonates when surgery is not possible.
• Further research is warranted to explore the efficacy and safety of octreotide in managing NEC.
• This case highlights the potential of pharmacological interventions in severe neonatal surgical emergencies.